Impact of Plasma Donepezil Concentration on Behavioral and Psychological Symptoms of Dementia in Patients with Alzheimer’s Disease
Background/Aims: The behavioral and psychological symptoms of dementia (BPSD) detract from the quality of life of not only dementia patients but also their family members and caregivers. Donepezil is used to treat Alzheimer’s disease and is metabolized via cytochrome P450 (CYP) 2D6 and CYP3A4/5. It...
Saved in:
Main Authors: | , , , , , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Karger Publishers
2021
|
Subjects: | |
Online Access: | https://doaj.org/article/9092d961ecd94bbf8758a46b3d1fdcea |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!